V025-1024 Screening compound: 3-[N-cyclohexyl-1-(2-methoxyphenyl)formamido]-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]propanamide

V025-1024 Screening compound: 3-[N-cyclohexyl-1-(2-methoxyphenyl)formamido]-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]propanamide
V025-1024 Screening compound: 3-[N-cyclohexyl-1-(2-methoxyphenyl)formamido]-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-1024
3-[N-cyclohexyl-1-(2-methoxyphenyl)formamido]-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-1024

Molecular Formula

C26H30N4O3S (C26 H30 N4 O3 S)

Compound Name

3-[N-cyclohexyl-1-(2-methoxyphenyl)formamido]-N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]propanamide

IUPAC name

3-[N-cyclohexyl-1-(2-methoxyphenyl)formamido]-N-[5-(4-methylphenyl)-134-thiadiazol-2-yl]propanamide

SMILES

Cc(cc1)ccc1-c1nnc(NC(CCN(C2CCCCC2)C(c(cccc2)c2OC)=O)=O)s1

InChI

InChI=1S/C26H30N4O3S/c1-18-12-14-19(15-13-18)24-28-29-26(34-24)27-23(31)16-17-30(20-8-4-3-5-9-20)25(32)21-10-6-7-11-22(21)33-2/h6-7,10-15,20H,3-5,8-9,16-17H2,1-2H3,(H,27,29,31)

InChI Key

IUCRRTJKOAZZTI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19716737

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

478.62

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.447

Distribution Coefficient, logD

5.447

Water Solubility, LogSw

-5.20

Polar Surface Area

69.454

Acid Dissociation Constant (pKa)

10.55

Base Dissociation Constant (pKb)

-0.15

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.50

V025-1024 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

GABA Library (7115 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Eye
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with V025-1024 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-1024?
Check Price and Availability of V025-1024, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-1024 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-1024
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-1024
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-1024 available by request